{"id":22953,"date":"2025-10-27T12:35:32","date_gmt":"2025-10-27T12:35:32","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=22953"},"modified":"2025-10-27T12:35:32","modified_gmt":"2025-10-27T12:35:32","slug":"chugai-pharmaceutical-to-acquire-renalys-pharma","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/","title":{"rendered":"\u4e2d\u5916\u88fd\u85ac\u306b\u3088\u308b\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u8cb7\u53ce\u306b\u3064\u3044\u3066"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><p>Chugai Pharmaceutical Co., Ltd. has made a firm deal to buy Renalys Pharma, Inc. This Tokyo biotech firm focuses on treating chronic kidney diseases. Chugai has exclusive rights to develop and sell sparsentan. This therapy treats IgA nephropathy. It&rsquo;ll be available in Japan, South Korea, and Taiwan.<\/p><p>\u30c8\u30e9\u30d9\u30fc\u30eb\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u88fd\u306e\u30b9\u30d1\u30fc\u30bb\u30f3\u30bf\u30f3\u306f\u3001\u7c73\u56fd\u3068\u6b27\u5dde\u3067\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002 <a href=\"https:\/\/renalys.com\/\" data-no-translation=\"\">Renalys Pharma<\/a>, founded to address Asia&rsquo;s &ldquo;drug lag,&rdquo; recently completed data collection for its Japan Phase III trial, with topline results expected in late 2025. The acquisition will accelerate regional access to sparsentan and strengthen Chugai&rsquo;s presence in nephrology and rare diseases.<\/p><p>\u672c\u5951\u7d04\u306b\u57fa\u3065\u304d\u3001\u4e2d\u5916\u88fd\u85ac\u306f\u5951\u7d04\u4e00\u6642\u91d1\u3068\u3057\u3066150\u5104\u5186\u3092\u652f\u6255\u3044\u307e\u3059\u304c\u3001\u898f\u5236\u4e0a\u306e\u30de\u30a4\u30eb\u30b9\u30c8\u30fc\u30f3\u3084\u8ca9\u58f2\u5b9f\u7e3e\u306b\u5fdc\u3058\u3066\u6700\u5927160\u5104\u5186\u306e\u30a2\u30fc\u30f3\u30a2\u30a6\u30c8\u304c\u767a\u751f\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p><h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/ajinomoto-bio-pharma-and-gene-tools-partner-on-pmo-therapy\/\" rel=\"bookmark\">\u5473\u306e\u7d20\u30d0\u30a4\u30aa\u30d5\u30a1\u30fc\u30de\u3068\u30b8\u30fc\u30f3\u30c4\u30fc\u30eb\u30ba\u304cPMO\u6cbb\u7642\u3067\u63d0\u643a<\/a><\/h4><p>Renalys CEO BT Slingsby stated that the partnership &ldquo;scales the company&rsquo;s mission to eliminate Asia&rsquo;s drug lag,&rdquo; while <a href=\"https:\/\/www.chugai-pharm.co.jp\/\" data-no-translation=\"\">Chugai Pharmaceutical<\/a>&rsquo;s expertise will ensure faster patient access across the region.<\/p>","protected":false},"excerpt":{"rendered":"<p>Chugai Pharmaceutical Co., Ltd. has made a firm deal to buy Renalys Pharma, Inc. This Tokyo biotech firm focuses on treating chronic kidney diseases. Chugai has exclusive rights to develop and sell sparsentan. This therapy treats IgA nephropathy. It&rsquo;ll be available in Japan, South Korea, and Taiwan.Sparsentan, made by Travere Therapeutics, is approved in the U.S. and Europe. Renalys Pharma, founded to address Asia&rsquo;s &ldquo;drug lag,&rdquo; recently completed data collection for its Japan Phase III trial, with topline results expected in late 2025. The acquisition will accelerate regional access to sparsentan and strengthen Chugai&rsquo;s presence in nephrology and rare diseases.Under the terms of the agreement, Chugai will make an upfront [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":22954,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,89,211,237,182,206],"tags":[1182,2637,8782,424,8783],"ppma_author":[572],"class_list":["post-22953","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-health-tech","category-japan","category-news","category-pharma","category-regional","tag-acquire","tag-chugai-pharmaceutical","tag-iga-nephropathy","tag-pharma","tag-renalys-pharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Chugai Pharma Set to Acquire Renalys Pharma<\/title>\n<meta name=\"description\" content=\"Chugai Pharmaceutical will acquire Renalys Pharma, gaining exclusive rights to develop and market in Japan, South Korea, and Taiwan.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chugai Pharma Set to Acquire Renalys Pharma\" \/>\n<meta property=\"og:description\" content=\"Chugai Pharmaceutical will acquire Renalys Pharma, gaining exclusive rights to develop and market in Japan, South Korea, and Taiwan.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-27T12:35:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Renalys-Pharma-to-be-Acquired-by-Chugai-Pharmaceutical.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u4e2d\u5916\u88fd\u85ac\u306b\u3088\u308b\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u8cb7\u53ce\u306b\u3064\u3044\u3066","description":"\u4e2d\u5916\u88fd\u85ac\u306f\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u3092\u8cb7\u53ce\u3057\u3001\u65e5\u672c\u3001\u97d3\u56fd\u3001\u53f0\u6e7e\u306b\u304a\u3051\u308b\u72ec\u5360\u7684\u958b\u767a\u30fb\u8ca9\u58f2\u6a29\u3092\u7372\u5f97\u3057\u307e\u3059\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/","og_locale":"ja_JP","og_type":"article","og_title":"Chugai Pharma Set to Acquire Renalys Pharma","og_description":"Chugai Pharmaceutical will acquire Renalys Pharma, gaining exclusive rights to develop and market in Japan, South Korea, and Taiwan.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/","og_site_name":"itbusinesstoday","article_published_time":"2025-10-27T12:35:32+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Renalys-Pharma-to-be-Acquired-by-Chugai-Pharmaceutical.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Chugai Pharmaceutical to Acquire Renalys Pharma","datePublished":"2025-10-27T12:35:32+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/"},"wordCount":184,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Renalys-Pharma-to-be-Acquired-by-Chugai-Pharmaceutical.webp","keywords":["acquire","Chugai Pharmaceutical","IgA nephropathy","Pharma","Renalys Pharma"],"articleSection":["APAC","Health Tech","Japan","News","Pharma","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/","name":"\u4e2d\u5916\u88fd\u85ac\u306b\u3088\u308b\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u8cb7\u53ce\u306b\u3064\u3044\u3066","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Renalys-Pharma-to-be-Acquired-by-Chugai-Pharmaceutical.webp","datePublished":"2025-10-27T12:35:32+00:00","description":"\u4e2d\u5916\u88fd\u85ac\u306f\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u3092\u8cb7\u53ce\u3057\u3001\u65e5\u672c\u3001\u97d3\u56fd\u3001\u53f0\u6e7e\u306b\u304a\u3051\u308b\u72ec\u5360\u7684\u958b\u767a\u30fb\u8ca9\u58f2\u6a29\u3092\u7372\u5f97\u3057\u307e\u3059\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Renalys-Pharma-to-be-Acquired-by-Chugai-Pharmaceutical.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Renalys-Pharma-to-be-Acquired-by-Chugai-Pharmaceutical.webp","width":1200,"height":800,"caption":"Renalys-Pharma"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/chugai-pharmaceutical-to-acquire-renalys-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Chugai Pharmaceutical to Acquire Renalys Pharma"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=22953"}],"version-history":[{"count":2,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22953\/revisions"}],"predecessor-version":[{"id":23000,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22953\/revisions\/23000"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/22954"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=22953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=22953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=22953"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=22953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}